Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...